The CXCR4/CXCL12 receptor/ligand pair has been shown to have a critical role in the progression of many kinds of cancers, including lung cancer,26 colon cancer,27 ovarian cancer,28 melanoma,29 leukemia 30 and breast cancer. Here, CXCR4 is linked to ovarian carcinoma.